21 CFR Subpart B - Subpart B—Labeling Requirements for Prescription Drugs and/or Insulin
- § 201.50 Statement of identity.
- § 201.51 Declaration of net quantity of contents.
- § 201.55 Statement of dosage.
- § 201.56 Requirements on content and format of labeling for human prescription drug and biological products.
- § 201.57 Specific requirements on content and format of labeling for human prescription drug and biological products described in § 201.56(b)(1).
- § 201.58 Waiver of labeling requirements.